Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectGlobal Markets for Treatments for Syndromes of Progressive Ataxia...
The global progressive ataxia and weakness disorders market reached $32.0 billion in 2022, should reach $35.1 billion by 2023 and $57.2 billion by 2028 with a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2023-2028.
Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast a...
The global acute myeloid leukemia (AML) treatments market should reach $6.1 billion by 2028 from $3.8 billion in 2023 at a compound annual growth rate (CAGR) of 10.0% for the forecast period of 2023 to 2028.
Minimal Residual Disease Testing: Global Markets and Technologies
The global market for minimal residual disease testing is estimated to increase from $2.2 billion in 2023 to reach $4.3 billion by 2028, at a compound annual growth rate (CAGR) of 14.3% from 2023 through 2028.
Cannabis: The Medicinal Use
This report provides its readers with the history, components, and types of Cannabis. It gives a brief picture of how cannabis is affecting different parts of the body and its use in different medical conditions. Having strong components makes it useful for medical purposes, but not everyone can access it, so having alternative plants with similar strains mentioned in the report will help the readers explore more alternatives. However, strict rules on the consumption and sale of cannabis are illegal so this report covers the regulations that have to be followed in the top 10 countries for the buying and selling of cannabis for medical purposes.
Veterinary Vaccines: Global Markets
The global veterinary vaccines market reached $9.1 billion in 2022, should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2023-2028.
Markets for Advanced Wound Management Technologies
The global advanced wound management products market reached $10.7 billion in 2022 and should reach $15.3 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2023-2028.
Epigenetic Therapeutics: Global Markets
The global market for epigenetic therapeutics is estimated to increase from $6.8 billion in 2023 to reach $9.8 billion by 2028, at a compound annual growth rate (CAGR) of 7.7% from 2023 through 2028.
Regenerative Medicines: Bone and Joint Applications
The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.
Antibiotics: Technologies and Global Markets
The global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.
Global Markets and Technologies for Pandemic Control
The global infectious diseases market reached $238.5 billion in 2022 and should reach $300.8 billion by 2027, with a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2022-2027.
Psychedelic Drugs: Global Market Outlook
The report provides an overview of the global psychedelic drugs market. This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends.
Transdermal Patches: Global Markets
The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.
Best Selling Pharmaceutical Drugs in 2021
This report discusses the pharmaceutical industry and its competitive landscape and sales of the top 50 bestselling drugs in 2021, in terms of major player market ranking and top 50 pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends have been well-researched and analyzed in this report.
Drugs of Abuse Testing: Technologies and Global Markets
The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.
Nasal Vaccines: Global Markets and Pipeline Analysis
The global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a compound annual growth rate (CAGR) of 8.2% from 2022 through 2027.
Helicobacter pylori Testing: Global Market Outlook
This report provides a brief general outlook of the global market for Helicobacter pylori testing. The report discusses the current and future strategies of vendors in the H. pylori testing market, which includes various invasive and non-invasive tests used to detect H. pylori. The revenues are broken down by region and have been estimated for the five-year period from 2022 through 2027. The report also present details with respect to Helicobacter pylori testing kits.
Bronchitis Treatments: Global Markets
The global market for bronchitis treatments is estimated to grow from $5.8 billion in 2022 to $6.9 billion in 2027, with a compound annual growth rate (CAGR) of 3.5% for the period of 2022-2027.
Regulatory Intelligence Report for Pharmaceuticals in the U.S.
This report presents an understanding of the regulations and requirements of companies in the U.S., as well as foreign companies or establishments planning to manufacture, distribute or market their pharmaceuticals in the U.S. This report provides a brief about the related regulations for registration of the establishments and pharmaceuticals.
Pediatric Vaccines: Global Markets
The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.
Head and Neck Cancer Therapeutics: Global Markets
The global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.5% from 2022 through 2027.
Laboratory Automation Systems and Processes: Global Markets and T...
The global market for laboratory automation systems and processes is valued at $11.9 billion in 2021 and is estimated to grow from $12.7 billion in 2022 to $18.7 billion in 2027 with a compound annual growth rate (CAGR) of 7.9% for the period of 2022-2027.
Clinical Infant Nutrition: Global Markets
The global clinical infant nutrition market reached $44.8 billion in 2021 and should reach more than $61.5 billion by 2026, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2021-2026.
Monoclonal Antibodies for Oncology: Global Markets
The global market for monoclonal antibodies in oncology is estimated to grow from $76.2 billion in 2022 to more than $138.1 billion by 2027, with a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2022-2027.
Preclinical Research Outsourcing Services: Global Markets
The global market for preclinical research outsourcing services should grown $5.6 billion in 2021 and should reach more than $8.3 billion in 2026, with a compound annual growth rate (CAGR) of 8.1%.
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...
The global market for circulating tumor cells (CTC) diagnostics is estimated to increase from $8.8 billion in 2021 to $15.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2021-2026.
Global Oncology Biosimilars Market
This report provides an overview of the global oncology biosimilars market and analyzes industry trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Global GLP-1 Analogues Market
The report provides an overview of the global market for GLP-1 Analogues. It includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2025 through 2030.
Global Artificial Intelligence (AI) in Clinical Trials Market
This report provides an overview of the global AI in clinical trials market. It focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Immunotherapy Drugs: Global Markets
This report will provide detailed information on immunotherapy drugs. This report analyzes the market trends with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030 (forecast period 2025 – 2030), and regional markets.
Monoclonal Antibodies for Oncology: Global Markets
This report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and opportunities. The report also covers market projections to 2030 and market share for key market players.
Radioligand Therapeutics in Cancer Treatment: Global Market
This report provides an analysis of radioligand therapeutics in cancer treatment market along with detailed profiles of key market players including a revenue product portfolio and recent activities. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030.
Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration
This report provides the detailed information on advanced drug delivery systems. This report analyzes the market trends of advanced drug delivery systems with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030, and regional markets of advanced drug delivery systems.
